4
Changes in Ownership
Protagenic Therapeutics, Inc.\new Filed Acc 0001493152-21-012357
Options or other derivatives
- Chief Financial Officer bought 30,000 shares at an average $0.31 ($9,420)
From the SEC's structured data for this filing
Trades in this filing
Arrow Alexander K. · Chief Financial Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-05-18 | Purchase : show line 1 in the form PTIXW Common Stock 5-year warrants strike price $4.98 | +12,000 | $0.32 | $3,840 | 12,000 | D |
| 2021-05-18 | Purchase : show line 2 in the form PTIXW Common Stock 5-year warrants strike price $4.98 | +18,000 | $0.31 | $5,580 | 30,000 | D |
Loading xslF345X03/ownership.xml…